3 terminated. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Terminated 3 |
Follow T Cell Lymphoma: new trials by email Literature Review of T Cell Lymphoma trials Research Report on T Cell Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| LCAR-T2C CAR-T Cells in Relapsed or Refractory CD4+ T Lymphocyte Tumor Efficacy of LCAR-T2C CAR-T cells - T Cell Lymphoma, T-cell Leukemia | Phase 1 | Terminated | Beijing Boren Hospital | 9 | 2021-07-02 | 2022-08-16 |
| A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory T or B Cell Malignancies (COBALT-LYM) CTX130 - T Cell Lymphoma | Phase 1 | Terminated | CRISPR Therapeutics AG | 49 | 2020-07-31 | 2025-01-08 |
| Intratumoral Poly-ICLC Plus Low Dose Local Radiation in Low Grade Recurrent B and T Cell Lymphoma Poly-ICLC - B Cell Lymphoma, T Cell Lymphoma | Phase 1 | Terminated | Nevada Cancer Institute | 3 | 2009-04-01 | 2011-07-20 |
Lymphoma, T-Cell (3) · Leukemia, T-Cell (1) · Lymphoma (1) · Lymphoma, B-Cell (1)
Hemic and Lymphatic Diseases (3) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Lymphatic Diseases (3) · Lymphoma, Non-Hodgkin (3) · Lymphoproliferative Disorders (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Lymphoma (2) · Hematologic Diseases (1) · Leukemia (1) · Leukemia, Lymphoid (1)
poly ICLC (1)
Beijing Boren Hospital (1) · CRISPR Therapeutics AG (1) · Nevada Cancer Institute (1)
United States (2) · Australia (1) · Canada (1) · China (1)
Alissa Keegan, PhD (1) · Delva Deauna-Limayo, MD (1) · Kai Hu, MD/PhD (1)